Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...
TOLOCHENAZ, Switzerland, Nov 15, 2010 (BUSINESS WIRE) -- Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and...
REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today it has received 510(k) clearance from the U.S. Food...
SAN ANTONIO & REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Innovative new mobile cardiac monitoring solutions are on the horizon. At the American Heart Association Scientific Sessions 2010,...
MINNEAPOLIS & CHICAGO, Nov 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the landmark RAFT (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial)...
MINNEAPOLIS, Nov 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2011 on Tuesday, November 23,...
MINNEAPOLIS, Nov 04, 2010 (BUSINESS WIRE) -- In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE:...
MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...
MINNEAPOLIS, Oct 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...
MINNEAPOLIS, Oct 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that it has entered into an agreement to settle existing U.S. lawsuits relating to its Sprint Fidelis(R)...
SAN FRANCISCO, Oct 13, 2010 (BUSINESS WIRE) -- To increase awareness of the debilitating effects of spinal fractures and the symptoms, causes and available treatments, American Bone Health;...
MEMPHIS, Tenn., Oct 06, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System Posted Screw Module. The announcement was...
MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Twenty-four Medtronic Global Heroes, long-distance runners who benefit from medical technology, successfully completed either the Medtronic Twin Cities...
MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...
MINNEAPOLIS, Oct 01, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Twin Cities In Motion (formerly Twin Cities Marathon, Inc.) announced they have signed a letter of intent to continue...
MINNEAPOLIS, Sep 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company's Reveal(R)
WASHINGTON, Sep 28, 2010 (BUSINESS WIRE) -- Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE: MDT), today announced...
MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...